Literature DB >> 9542630

Integrins: utility as cell type- and stage-specific markers for hepatocellular carcinoma and cholangiocarcinoma.

M Enjoji, H Sakai, M Nakashima, H Nawata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9542630     DOI： 10.1007/s11626-998-0047-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  12 in total

1.  Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine.

Authors:  M Enjoji; M Nakashima; M Honda; H Sakai; H Nawata
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

2.  Is there a liver stem cell?

Authors:  S Sell
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

Review 3.  Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms.

Authors:  N Marceau
Journal:  Lab Invest       Date:  1990-07       Impact factor: 5.662

4.  Promotion of growth and differentiation of rat ductular oval cells in primary culture.

Authors:  L Germain; M Noël; H Gourdeau; N Marceau
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

5.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

Authors:  F J de Sauvage; P E Hass; S D Spencer; B E Malloy; A L Gurney; S A Spencer; W C Darbonne; W J Henzel; S C Wong; W J Kuang
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

6.  Distribution of the VLA family of integrins in normal and pathological human liver tissue.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

7.  Integrins as differential cell lineage markers of primary liver tumors.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining.

Authors:  G Koukoulis; A Rayner; K C Tan; R Williams; B Portmann
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

9.  Characterization of ductular hepatocytes in end-stage cirrhosis.

Authors:  A M Vandersteenhoven; J Burchette; G Michalopoulos
Journal:  Arch Pathol Lab Med       Date:  1990-04       Impact factor: 5.534

10.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

Authors:  P R Galle; W J Hofmann; H Walczak; H Schaller; G Otto; W Stremmel; P H Krammer; L Runkel
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307
View more
  3 in total

1.  Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells.

Authors:  M Enjoji; K Kotoh; H Iwamoto; M Nakamuta; H Nawata
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

Review 2.  Surgical management of proximal bile duct cancers.

Authors:  Jennifer LaFemina; William R Jarnagin
Journal:  Langenbecks Arch Surg       Date:  2012-03-06       Impact factor: 3.445

3.  Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.

Authors:  Peter Nagi; Selwyn M Vickers; Julia Davydova; Yasuo Adachi; Koichi Takayama; Shannon Barker; Victor Krasnykh; David T Curiel; Masato Yamamoto
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.